From: HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase InhibitorsA Randomized,
Controlled Trial
Ann Intern Med. 2015;163(12):908-917. doi:10.7326/M15-0949
Figure Legend:
Time to regimen failure.
Results in panel A are from an intention-to-treat analysis (all randomly assigned participants included). Results in panels B, C, and D are from an as-treated analysis (only participants who started study treatment; events
occurring after discontinuation of NRTI assignment are censored). NRTI = nucleoside reverse transcriptase inhibitor. A. Secondary efficacy outcome: Time to primary outcome of regimen failure (first virologic failure or
discontinuation of NRTI strategy). B. Primary safety outcome: Time to first grade 3 or 4 sign, symptom, or laboratory abnormality ≥1 grade higher than baseline. C. Secondary safety outcome: Time to first grade 3 or 4 sign
or symptom ≥1 grade higher than baseline. D. Secondary safety outcome: Time to first grade 3 or 4 laboratory abnormality ≥1 grade higher than baseline.
Date of download: 7/28/2017
Copyright © American College of Physicians. All rights reserved.